Novel 2-thioxanthine and dipyrimidopyridine derivatives: Synthesis and antimicrobial activity

Article abstract of DOI:10.3390/molecules201019263

Several fused imidazolopyrimidines were synthesized starting from 6-amino-1- methyl-2-thiouracil (1) followed by nitrosation, reduction and condensation with different aromatic aldehydes to give Schiff's base. The dehydrocyclization of Schiff's bases using iodine/DMF gave Compounds 5a-g. The methylation of 5a-g using a simple alkylating agent as dimethyl sulfate ((CH3)2SO4) gave either monoalkylated imidazolopyrimidine 6a-g at room temperature or dialkylated derivatives 7a-g on heating 6a-g with ((CH3)2SO4). On the other hand, treatment of 1 with different aromatic aldehydes in absolute ethanol in the presence of conc. hydrochloric acid at room temperature and/or reflux with acetic acid afforded bis-5,5′-diuracylmethylene 8a-e, which cyclized on heating with a mixture of acetic acid/HCl (1:1) to give 9a-e. Compounds 9a-e can be obtained directly by refluxing of Compound 1 with a mixture of acetic acid/HCl. The synthesized new compounds were screened for antimicrobial activity, and the MIC was measured.

Full text of DOI:10.3390/molecules201019263

Molecules 2015, 20, 19263-19276; doi:10.3390/molecules201019263
OPEN ACCESS
molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article
Novel 2-Thioxanthine and Dipyrimidopyridine Derivatives:
Synthesis and Antimicrobial Activity †
Samar El-kalyoubi 1,*, Fatmah Agili 2 and Shaker Youssif 3,4
1
Organic Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University,
Nasr City 11651, Egypt
2
Chemistry Department, Faculty of Science, Jazan University, Jazan (Female Section) 45142,
Saudi Arabia; E-Mail: dr.fatmah2000@gmail.com
3
Medical Chemistry Division, Faculty of Medicine, Jazan University, Jazan 82621, Saudi Arabia;
E-Mail: syoussif@hotmail.com
4
Chemistry Department, Faculty of Science, Zagazig University, Zagazig 44511, Egypt
†
Oral Presentation at the 1st International Turkic World Conference on Chemical Sciences and
Technologies October 2015.
* Author to whom correspondence should be addressed; E-Mail: s.elkalyoubi@hotmail.com;
Tel.: +20-10-9535-9392; Fax: +20-55-234-8023.
Academic Editor: Philippe Belmont
Received: 22 August 2015 / Accepted: 12 October 2015 / Published: 22 October 2015
Abstract: Several fused imidazolopyrimidines were synthesized starting from 6-amino-1-
methyl-2-thiouracil (1) followed by nitrosation, reduction and condensation with different
aromatic aldehydes to give Schiff’s base. The dehydrocyclization of Schiff’s bases using
iodine/DMF gave Compounds 5a–g. The methylation of 5a–g using a simple alkylating
agent as dimethyl sulfate ((CH3)2SO4) gave either monoalkylated imidazolopyrimidine 6a–g
at room temperature or dialkylated derivatives 7a–g on heating 6a–g with ((CH3)2SO4). On
the other hand, treatment of 1 with different aromatic aldehydes in absolute ethanol in the
presence of conc. hydrochloric acid at room temperature and/or reflux with acetic acid
afforded bis-5,5́-diuracylmethylene 8a–e, which cyclized on heating with a mixture of
acetic acid/HCl (1:1) to give 9a–e. Compounds 9a–e can be obtained directly by refluxing of
Compound 1 with a mixture of acetic acid/HCl. The synthesized new compounds were
screened for antimicrobial activity, and the MIC was measured.

Molecules 2015, 20
19264
Keywords: 6-amino-2-thiouracil; 6-amino-5-benzylideneamino-2-thiouracil; 8-aryl-3-methyl-
2-thioxanthines; 8-aryl-3-methyl-2-methylthiopurine-6-ones
1. Introduction
The importance of fused uracils, a common source for the development of new potential therapeutic
agents [1,2], is well known. Fused uracils continue to attract considerable attention because of their great
practical usefulness, primarily due to a very wide spectrum of biological activities. Uracils and their
derivatives are considered to be important for drugs. A large number of uracil derivatives are reported to
exhibit antimycobacterial [3], antitumor [4], antiviral [5] and anticancer [6,7] activities. In recent years,
considerable attention has been focused on the development of new methodologies to synthesize many
kinds of xanthine rings. Indeed, purines represent an important class of heterocyclic compounds having
wide range of pharmaceutical and biological activities. The replacement of the oxygen by a sulfur atom
may induce changes in the properties of the nucleobases and the ability to stabilize the DNA [8,9].
Furthermore, it has been suggested that the presence of the thio-group may enhance the probability
of mutations that occur in DNA [10]. Therefore, versatile and widely-applicable methods for the
synthesis of thiopurines are of considerable interest. On the other hand, acridine derivatives are known
as antibacterial [11] and antitumor drugs [12,13] with clinical importance. The mechanism of the
antibacterial action of acridine derivatives seems to be connected to the intercalation to DNA [14].
1-Aza analogues of aminacrine and rivanol were, however, shown to be more active than the parent
compounds against a hemolytic streptococcal strain [15], analogues of aminacrine and rivanol derived
from 1:10-diazaanthracenes [16–18].
Our strategy has been directed towards the synthesis of a series of new thiouracil fused ring analogs,
and their biological effects are determined.
2. Results and Discussion
2.1. Chemistry
2-Thioxanthine [19] and 3-methyl-2-thioxanthine were previously prepared by different methods [20,21].
The alkylation of N-H or S-H takes place by many different reported methods in the literature [22,23].
Herein, we use one of the simplest methylating agents and a simple method. 8-Aryl-3-methyl-2-
thioxanthines (5a–g) [21] were synthesized by the treatment of 6-amino-1-methyl-2-thiouracil (1) with
sodium nitrite in acetic acid, affording 5-nitrosouracil 2, followed by the reduction using ammonium
sulfide, giving 4,5-diaminouracil 3. The obtained Compound 3 was condensed with different aromatic
aldehydes in ethanol, affording 5-arylideneaminouracil 4a–g, which undergoes dehydrocyclization via
the reaction with I2/DMF, giving 5a–g in a good yield. Methylation of 5a–g takes place by the reaction
with dimethyl sulfate in 0.5 N NaOH and ethanol for 1 h at room temperature with stirring to produce
the target mono-alkylated thioxanthines 6a–g; the methylation takes place smoothly on S-H (C-2). While
refluxing of 6a–g with dimethyl sulfate in 0.5 N NaOH and ethanol for 1 h gave 7a–g, the methylation
was carried out on N-H (C-9), as well as on the -OH group of the phenyl-8 in 7f,g as shown in Scheme 1.

Molecules 2015, 20
19265
The structures of the synthesized compounds were proven by 1H-NMR, elemental analysis, mass and IR
spectra. 1H-NMR (DMSO-d6) for Compounds 6a–g showed a characteristic signals at 4.0–4.54 ppm for
S-CH3 and a characteristic signal at 10.02–11.11 ppm for N-H (9), while Compounds 7a–f showed the
disappearance of N-H (9) signals and the appearance of new N-CH3 at 3.38–3.79 ppm. Mass spectra of
Compound 6b showed fragmentation at M+ + 2 = 308, M+ = 306, and Compound 7b showed M+ + 2 = 322,
M+ = 320, due to the presence of the Cl atom attached to the phenyl group, as well as in compound 6d
showed fragmentation at M+ + 2 = 353, M+ = 351, and 7d M+ + 2 = 367, M+ = 365, due to the presence
of the Br atom; also, Ms of compounds 7f showed M+ = 316, which explain the methylation of para OH
of the phenyl group 8.
R
O
O
O
O
NO
NH2
NH2
N
HN
HN
HN
HN
ii
iii
i
S
N
S
N
NH2
S
N
S
N
NH2
NH2
CH3
CH3
4a-g
CH3
CH3
3
2
1
iv
O
O
O
N
N
v
N
N
N
vi
HN
N
N
H
N
H
N
H3CS
N
R
N
R
H3CS
R
S
CH3
CH3
CH3
CH3
5a-g
6a-g
7a-g
i = NaNO2/AcOH/r.t.; ii = (NH4)2S; iii = ArCHO/EtOH; iv = I2/DMF; v = (CH3)2SO4/NaOH/EtOH/r.t;
vi = (CH3)2SO4/NaOH/EtOH/reflux; where R in 6a–g are: a = H; b = 4-Cl; c = 2-OCH3; d = 4-Br; e = 4-F;
f = 4-OH; g = 2-OH; R in 7a–g are: a = H; b = 4-Cl; c = 2-OCH3; d = 4-Br; e = 4-F; f = 4-OCH3; g = 2-OCH3.
Scheme 1. Synthesis of 8-aryl-3,9-dimethyl-2-methylthio-3,9-dihydro-6H-purin-6-one.
As part of our synthetic studies of fused uracils, we have reported the synthesis of
dipyrimidopyridines [24,25]. Refluxing of Compound 1 with different aromatic aldehydes in acetic acid
and/or absolute ethanol in the presence of conc. hydrochloric acid with stirring at room temperature
produced the bis derivatives 8a–e, which on refluxing compound 8a for 1 h with a mixture of AcOH/HCl
afforded the dipyrimidopyridine derivatives 9a. Compounds 9a–e can be synthesized directly in one
step by refluxing Compound 1 with a mixture of AcOH/HCl for 4–6 h, as shown in Scheme 2. 1H-NMR
(DMSO-d6) of Compounds 8a–e showed a characteristic signal at 5.46–5.62 ppm for CH-5 and at
7.58–7.92 for NH2 (6), while 1H-NMR for Compounds 9a–e showed a characteristic signals at 7.88–8.46
for NH-10 and at 6.06–6.22 for CH-5.

Molecules 2015, 20
19266
R
O
CHO
O
N
O
AcOH/reflux or
HN
NH
HN
+
NH2
absolute EtOH/AcOH/r.t.
S
N
S
S
N
R
NH2 H2N
CH3
1
CH3
CH3
8a-e
R
O
O
N
HN
NH
S
N
N
H
S
CH3
CH3
9a-e
Ar: a = 4-Cl-C6H4; b = 3-NO2-C6H4; c = 4-NO2-C6H4; d = 4-Br-C6H4; e = 2-HO-C6H4.
Scheme 2. Reactions of aromatic aldehydes with 6-amino-1-methyl-2-thiouracil.
2.2. Antimicrobial Screening
Results in Table 1 reveal that there is a vast variation between tested microorganisms, whereas
Escherichia coli as a negative bacterial strains tolerate the applicable organic compounds. On the other
hand, S. aureus is a positive bacterial strain affected by the application of Compounds 7d, 8c and 9a. The
most obvious inhibition zone was developed with Compound 7d with the MIC reaching 0.4 µg followed
by Compounds 9a (MIC = 0.3 µg) and 8d (the lowest effect). It is worth mentioning that the inhibitory
effect induced by Compound 7d was three-fold more than Compound 8d. With respect to C. albicans,
it is affected by Compounds 7b, 7d, 8c and 9a with the inhibition zone ranging between 8.3 and 16.0 mm.
The highest inhibition was developed after application of Compound 9a (16 mm) with the MIC reaching
to 0.5 µg/mL.
3. Experimental Section
3.1. General
Melting points were determined with an Electro Thermal Mel-Temp II apparatus and are uncorrected.
All reactions were monitored by thin layer chromatography (TLC) on pre-coated silica gel plates (0.25 mm,
20 × 20 cm, 60F254, E. Merck KGaA, Konstanz, Germany) with an appropriate solvent system ((A) 1:9
CH3OH–CHCl3; (B) 1:1 tolune–ethylacetate). IR spectra were obtained in the solid state in the form
of KBr discs using a Perkin-Elmer Model 1430 spectrometer (Perkin-Elmer, Akron, OH, USA) and
carried out in Taif University, Taif, KSA. 1H-NMR spectra were run at 400 MHz and 13C spectra were

Molecules 2015, 20
19267
run at 125 MHz in dimethylsulfoxide (DMSO-d6) and TMS as an internal standard. Mass spectra were
recorded on GC Ms-QP 5050A mass spectrometer (Shimadzu Corporation, Tokyo, Japan) at 70 eV and
microanalytical data were performed on Elementar Vario EI III CHN analyzer (Elementar, Langenselbold,
Germany) at the microanalytical unit, in Regional center for Mycology and Biotechnology, Al-Azhar
University, Nasr City, Egypt.
Table 1. Detection of the antimicrobial activity of some organic compounds by measuring
the formed inhibition zone (inhibition zone measured in mm and MIC in µg/mL).
Compd. No. Staphylococcus aureus Escherichia coli
Candida albicans
6a
6b
6c
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6d
6e
0
0
0
0
6f
0
0
6g
0
0
7a
0
0
7b
7c
0
8.3 ± 0.881
0
0
7d
7e
15.3 ± 0.88 * (0.4)
12.6 ± 1.1547 * (0.3)
0
0
7f
0
0
8a
0
0
8b
8c
0
0
5.0 ±0.9 *
12.3 ± 0.91 * (0.3)
8d
8e
0
0
0
0
9a
14.6 ± 1.2 * (0.5)
16.0 ± 1.1547 * (0.5)
9b
9c
0
0
0
0
0
0
0
0
0
0
9d
9e
DMSO
* ±SE: standard error for three measurements; MIC: the value indicated between the brackets.
3.2. Synthesis of 8-Aryl-3-methyl-2-methylthio-3,9-dihydro-3,6H-purin-6-one (6a–g)
Dimethyl sulfate (7.0 mL) was added to a mixture of NaOH (12.5 mL, 0.5 N) and 2-thioxanthines
5a–g (5 mmol). Ethanol was added gradually till completely dissolving of 2-thioxanthines. The mixture
was stirred for 1 h at room temperature; the formed precipitate was collected by filtration, dried in the
oven and crystallized from DMF/ethanol.
3-Methyl-2-(methylthio)-8-phenyl-3,9-dihydro-6H-purin-6-one (6a). Yield: 70%; m.p. >300 °C; IR (KBr)
νmax (cm−1): 3425 (NH), 3055 (CH aromatic), 2921 (CH aliphatic), 1688 (C=O), 1617 (C=N), 1290 (NH);
1H-NMR (DMSO-d6): 11.11 (s, 1H, NH), 7.83–7.77 (m, 2H, arom.), 7.58–7.55 (m, 3H, arom.), 4.03 (s, 3H,

Molecules 2015, 20
19268
13
SCH3), 3.83 (s, 3H, NCH3); C-NMR (DMSO-d6): δ = 16.4 (SCH3), 29.28 (NCH3), 108.24, 114.40,
122.78, 128.01, 136.68, 142.92 (C-S), 150.76, 154.15, 154.17 (C=O) ppm; MS: m/z (%) = M+, 272 (7),
256 (9), 213 (16), 82 (100); Anal. calcd. for C13H12N4OS (272.32): C, 57.34; H, 4.44; N, 20.57. Found:
C, 57.49; H, 4.51; N, 20.72.
8-(4-Chlorophenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6b). Yield: 78%; m.p. >300 °C;
IR (KBr) νmax (cm−1): 3473 (NH), 3013 (CH arom.), 2955 (CH aliph.),1687 (C=O), 1612 (C=N), 1265
1
(NH); H-NMR (DMSO-d6): 10.31 (s, 1H, NH), 7.84–7.61 (d, 2H, J = 8.7, arom.), 7.60–7.58 (d, 2H,
J = 8.4, arom.), 4.54 (s, 3H, SCH3), 3.63 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 16.6 (SCH3),
29.26 (NCH3), 107.21, 113.41, 122.78, 128.01, 136.68, 141.90 (C-S), 149.88, 153.18, 153.89 (C=O)
ppm; MS: m/z (%) = M+ +2, 308 (19), M+ + 1, 307 (15), M+, 306 (54), 171 (33), 111 (28), 68 (100).
Anal. calcd. for C13H11ClN4OS (306.77): C, 50.90; H, 3.61; N, 18.26. Found: C, 51.08; H, 3.94; N, 18.47.
8-(2-Methoxyphenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6c). Yield: 67%; m.p. >300 °C;
IR (KBr) νmax (cm−1): 3450 (NH), 3076 (CH arom.), 2928 and 2838 (CH aliph.), 1694 (C=O), 1629
(C=N), 1286 (NH); 1H-NMR (DMSO-d6): 10.76 (s, 1H, NH), 8.04–8.01 (d, 1H, J = 1.8, arom.), 7.51–7.50
(m, 1H, arom.), 7.22–7.19 (d, 1H, J = 8.4, arom.), 7.12–7.07 (m, 1H, J = 7.5, arom.), 4.43(s, 3H, SCH3),
3.93 (s, 3H, OCH3), 3.84 (s, 3H, NCH3). MS: m/z (%) = M+, 302 (95), 257 (51), 134 (65), 68 (100).
Anal. calcd. for C14H14N4O2S (302.35): C, 55.61; H, 4.67; N, 18.53. Found: C, 55.74; H, 4.74; N,
18.69.
8-(4-Bromophenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6d). Yield: 78%; m.p. >300 °C; IR
(KBr) νmax (cm−1): 3446 (NH), 3080 (CH arom.), 2924 and 2853 (CH aliph.), 1697 (C=O), 1633 (C=N),
1208 (NH); 1H-NMR (DMSO-d6): 10.88 (s, 1H, NH), 7.89–7.87 (d, 2H, J = 8.4, arom.), 7.59–7.56 (d,
2H, J = 8.1, arom.), 4.43 (s, 3H, SCH3), 3.82 (s, 3H, NCH3).MS: m/z (%) = M+ + 2, 353 (6), M+, 351 (9),
336 (12), 68 (100); Anal. calcd. for C13H11BrN4OS (351.22): C, 44.46; H, 3.16; N, 15.95. Found: C,
44.62; H, 3.12; N, 16.14.
8-(4-Fluorophenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6e). Yield: 64%; m.p. >300 °C; IR
(KBr) νmax (cm−1): 3526 (NH), 3082 (CH arom.), 2933 and 2827 (CH aliph.), 1684 (C=O), 1625 (C=N),
1
1216 (NH); H-NMR (DMSO-d6): 11.02 (s, 1H, NH), 7.69–7.54 (m, 2H, arom.), 7.30–7.25 (m, 2H,
arom.), 4.14 (s, 3H, SCH3), 3.72 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 16.3 (SCH3), 29.23 (NCH3),
107.11, 113.42, 122.64, 127.89, 141.48 (C-S), 146.57, 149.83, 153.01, 154.23 (C=O) ppm; MS: m/z
(%) = M+ + 1, 291 (16), M+, 290 (27), 122 (32), 68 (100); Anal. calcd. for C13H11FN4OS (290.31): C,
53.78; H, 3.82; N, 19.30. Found: C, 53.87; H, 3.89; N, 19.37.
8-(4-Hydroxyphenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6f). Yield: 63%; m.p. >300 °C;
IR (KBr) νmax (cm−1): 3615 (OH), 3406 (NH), 3071 (CH arom.), 2938 and 2839 (CH aliph.), 1700 (C=O),
1
1602 (C=N), 1253 (NH); H-NMR (DMSO-d6): 13.23 (s, 1H, OH), 10.02 (s, 1H, NH), 7.66–7.65 (d,
2H, J = 4.2, arom.), 6.88–6.86 (d , 2H, J = 6.9, arom.), 4.21 (s, 3H, SCH3), 3.83 (s, 3H, NCH3).MS:
m/z (%) = M+, 288 (34), 258 (7), 120 (23), 82 (100), 67 (60); Anal. calcd. for C13H12N4O2S (288.32):
C, 54.15; H, 4.20; N, 19.43. Found: C, 54.29; H, 4.27; N, 19.66.

Molecules 2015, 20
19269
8-(2-Hydroxyphenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6g). Yield: 58%; m.p. >300 °C;
IR (KBr) νmax (cm−1): 3632 (OH), 3400 (NH), 3062 (CH arom.), 2925 and 2829 (CH aliph.), 1688 (C=O),
1
1624 (C=N), 1251 (NH); H-NMR (DMSO-d6): 13.12 (s, 1H, OH), 10.98 (s, 1H, NH), 7.82–7.81 (d,
1H, J = 1.5, arom.), 7.15–7.01 (m, 2H, arom.), 6.87–6.80 (m, 1H, arom.), 4.29 (s, 3H, SCH3), 3.79 (s, 3H,
NCH3); 13C-NMR (DMSO-d6): δ = 16.21 (SCH3), 28.98 (NCH3), 107.10, 113.41, 122.55, 127.72,
128.17, 136.61, 139.29, 141.32 (C-S), 149.83, 152.24, 154.13 (C=O) ppm; MS: m/z (%) = M+, 288
(100), 274 (33), 215 (74), 120 (69); Anal. calcd. for C13H12N4O2S (288.32): C, 54.15; H, 4.20; N,
19.43. Found: C, 54.21; H, 4.24; N, 19.62.
3.3. 8-Aryl-3,9-dimethyl-2-methylthio-3,9-dihydro-6H-purin-6-one (7a–g)
Dimethyl sulfate (7.0 mL) was added to a mixture of NaOH (12.5 mL, 0.5 N) and 2-thioxanthines
6a–g (5 mmol), and ethanol was added gradually till 2-thioxanthines were completely dissolved. The
mixture was heated under reflux for 1 h with stirring. The reaction mixture was evaporated under
reduced pressure, and the residue was collected by filtration and crystallized from ethanol to afford
Compounds 7a–g.
3,9-Dimethyl-2-(methylsulfanyl)-8-phenyl-3,9-dihydro-6H-purin-6-one (7a). Yield: 78%; m.p. >300 °C;
IR (KBr) νmax (cm−1): 3059 (CH arom.), 2980 (CH aliph.),1687 (C=O), 1609 (C=N); 1H-NMR (DMSO-d6):
7.79–7.76 (m, 2H, arom.), 7.54–7.51 (m, 3H, arom.), 4.00 (s, 3H, SCH3), 3.83 (s, 3H, NCH3), 3.72 (s, 3H,
NCH3); 13C-NMR (DMSO-d6): δ = 16.18 (SCH3), 29.38 (NCH3), 44.18 (NCH3), 108.13, 113.27,
122.42, 127.89, 136.57, 141.48 (C-S), 149.83, 153.01, 154.21 (C=O) ppm; MS: m/z (%) = M+, 286
(67), 82 (100); Anal. calcd. for C14H14N4OS (286.35): C, 58.72; H, 4.93; N, 19.57. Found: C, 58.89; H,
4.98; N, 19.64.
3,9-Dimethyl-2-(methylsulfanyl)-8-(4-chlorophenyl)-3,9-dihydro-6H-purin-6-one (7b). Yield: 82%;
m.p. >300 °C; IR (KBr) νmax (cm−1): 3068 (CH arom.), 2970 (CH aliph.), 1676 (C=O), 1623 (C=N);
1H-NMR (DMSO-d6): 7.62–7.60 (d, 2H, arom.), 7.55–7.52 (d, 2H, arom.), 4.03 (s, 3H, SCH3), 3.80 (s,
3H, NCH3), 3.66 (s, 3H, NCH3); MS: m/z (%) = M+ + 2, 322 (13), M+, 320 (30), 307 (16), 86 (11), 68
(100); Anal. calcd. for C14H13ClN4OS (320.79): C, 52.42; H, 4.08; N, 17.46. Found: C, 52.49; H, 4.13;
N, 17.59.
3,9-Dimethyl-2-(methylsulfanyl)-8-(2-methoxyphenyl)-3,9-dihydro-6H-purin-6-one (7c). Yield: 71%;
m.p. >300 °C; IR (KBr) νmax (cm−1): 3092 (CH arom.), 2838 (CH aliph.), 1699 (C=O), 1633 (C=N);
1H-NMR (DMSO-d6): 7.46–7.45 (m, 1H, arom.), 7.26–7.23 (m, 2H, arom.), 7.13–7.09 (m, 1H, arom.),
13
4.13 (s, 3H, SCH3), 3.93 (s, 3H, OCH3), 3.79 (s, 3H, NCH3), 3.70 (s, 3H, NCH3); C-NMR (DMSO-
d6): δ = 16.31 (SCH3), 29.27 (NCH3), 44.16 (NCH3), 52.01 (OCH3), 111.29, 118.23, 123.27, 124.42,
127.89, 128.13, 139.51, 141.58 (C-S), 152.83, 153.81, 154.41 (C=O) ppm; MS: m/z (%) = M+, 316
(21), 302 (100), 287 (13), 243 (12), 119 (8), 70 (11), 64 (12); Anal. calcd. for C15H16N4O2S (316.37):
C, 56.94; H, 5.10; N, 17.71. Found: C, 57.21; H, 5.17; N, 17.83.
3,9-Dimethyl-2-(methylsulfanyl)-8-(4-bromophenyl)-3,9-dihydro-6H-purin-6-one (7d). Yield: 79%;
m.p. >300 °C; IR (KBr) νmax (cm−1): 3079 (CH arom.), 2953(CH aliph.), 2841 (CH aliph.), 1689 (C=O),

Molecules 2015, 20
19270
1
1617 (C=N); H-NMR (DMSO-d6): 8.06–8.02 (m, 2H, arom.), 7.69–7.67 (m, 2H, arom.), 4.41 (s, 3H,
SCH3), 3.74 (s, 3H, NCH3), 3.39 (s, 3H, NCH3); MS: m/z (%) = M+ + 2, 367 (8), M+, 365 (12), 348
(22), 68 (100); Anal. calcd. for C14H13BrN4OS (365.24): C, 46.04; H, 3.59; N, 15.34. Found: C, 46.19;
H, 3.66; N, 15.46.
3,9-Dimethyl-2-(methylsulfanyl)-8-(4-fluorophenyl)-3,9-dihydro-6H-purin-6-one (7e). Yield: 69%;
m.p. >300 °C; IR (KBr) νmax (cm−1): 3074 (CH arom.), 2921 (CH aliph.), 2827 (CH aliph.), 1693 (C=O),
1
1618 (C=N), 1257 (NH); H-NMR (DMSO-d6): 7.87–7.84 (m, 2H, arom.), 7.40–7.36 (m, 2H, arom.),
4.03 (s, 3H, SCH3), 3.78 (s, 3H, NCH3), 3.67 (s, 3H, NCH3); MS: m/z (%) = M+ + 1, 305 (6), M+, 304
(18), 171 (33), 122 (54), 68 (100); Anal. calcd. for C14H13FN4OS (304.34): C, 55.25; H, 4.31; N, 18.41.
Found: C, 55.34; H, 4.34; N, 18.56.
3,9-Dimethyl-8-(4-methoxyphenyl)-2-(methylsulfanyl)-3,9-dihydro-6H-purin-6-one (7f). Yield: 72%;
m.p. >300 °C; IR (KBr) νmax (cm−1): 3076 (CH arom.), 2928 (CH aliph.), 2839 (CH aliph.), 1695
1
(C=O), 1619 (C=N); H-NMR (DMSO-d6): 7.97–7.94 (d, 2H, arom.), 6.93–6.91 (d , 2H, arom.), 4.30
(s, 3H, SCH3), 4.05 (s, 3H, OCH3), 3.77 (s, 3H, NCH3), 3.64 (s, 3H, NCH3); MS: m/z (%) = M+, 316
(18), 302 (56), 268 (100), 214 (24); Anal. calcd. for C15H16N4O2S (316.37): C, 56.94; H, 5.10; N,
17.71. Found: C, 57.21; H, 5.07; N, 17.62.
3,9-Dimethyl-8-(2-methoxyphenyl)-2-(methylsulfanyl)-3,9-dihydro-6H-purin-6-one (7g). Yield: 67%;
m.p. >300 °C; Anal. calcd. for C15H16N4O2S (316.37): C, 56.94; H, 5.10; N, 17.71. Found: C, 57.18;
H, 5.13; N, 17.85.
3.4. Synthesis of 5,5′-Arylmethylenebis-(6-Amino-1-methyl-2-thiouracil) (8a–e)
A mixture of 6-amino-1-methyl-2-thiouracil (1) (0.5 g, 2.4 mmol) and appropriate aromatic aldehydes
(2.4 mmol) in absolute ethanol (20 mL) in the presence of conc. Hydrochloric acid (1mL) was stirred at
room temperature for 1.5 h and/or reflux with glacial acetic acid (5 mL) for 1 h. The formed precipitate
was filtered, washed with ethanol and crystallized from DMF/ethanol (3:1) into colorless crystals.
5,5'-[(4-Chlorophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8a).
Yield: 95%; m.p. = 240–242 °C; IR (KBr) νmax (cm−1): 3442, 3340 (NH2 and NH), 3064 (CH arom.),
2871 (CH aliph.), 1732, 1662 (C=O), 1598 (C=C), 1086, 1119 (C=S), 747 (C-Cl); 1H-NMR (DMSO-d6):
12.28 (s, 2H, 2NH), 7.59 (bs, 4H, 2NH2), 7.26–7.24 (d, J = 5.9, 2H, arom.), 7.15–7.13 (d, J = 9.2, 2H,
13
arom.), 5.48 (s, 1H, CH-5), 3.77 (s, 6H, 2 CH3); C-NMR (DMSO-d6): δ = 28.4 (CH), 38.7 (CH3),
91.2, 111.9, 117.2, 126.1, 129.3, 151.3, 162.2 (C=O), 171.1 (C=S) ppm; MS: m/z (%) = M+ + 2, 439
(8), M+ + 1, 438 (15), M+, 437 (22), 156 (82), 124 (77), 88 (100); Anal. calcd. for C17H17ClN6O2S2
(436.93): C, 46.73; H, 3.92; N, 19.23. Found: C, 46.98; H, 3.98; N, 19.42
5,5'-[(3-Nitrophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8b).
Yield: 88%; m.p. = 258–260 °C; IR (KBr) νmax (cm−1): 3406, 3335 (NH2 and NH), 3057 (CH arom.),
2833 (CH aliph.), 1731, 1690 (C=O), 1528 (C=N), 1128, 1081 (C=S); 1H-NMR (DMSO-d6): 12.34 (s,
2H, 2NH), 8.03–8.01 (d, 1H, arom.), 7.9 (d, 1H, arom.), 7.63–7.61 (bs, 4H, 2 NH2), 7.54–7.50 (m, 2H,
arom.), 5.60 (s, 1H, CH-5), 3.79 (s, 6H, 2 CH3); MS: m/z (%) = M+, 447 (37), 358 (48), 325 (18), 286

Molecules 2015, 20
19271
(100); Anal. calcd. for C17H17N7O4S2 (447.49): C, 45.63; H, 3.83; N, 21.91. Found: C, 45.85; H, 3.88;
N, 22.14.
5,5'-[(4-Nitrophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8c).
Yield: 90%; m.p. = 261–263 °C; IR (KBr) νmax (cm−1): 3450, 3328 (NH2 and NH), 3051 (CH arom.),
2992 (CH aliph.), 1714, 1663 (C=O), 1563 (C=N), 1116, 1086 (C=S); 1H-NMR (DMSO-d6): 12.34 (s,
2H, 2NH), 8.09–8.06 (d, J = 5.8, 2H, arom), 7.61 (bs, 4H, 2 NH2), 7.43–7.41 (d, J = 8.8, 2H, arom.),
5.59 (s, 1H, CH-5), 3.78 (s, 6H, 2 CH3); 13C-NMR (DMSO-d6): δ = 28.6 (CH), 39.2 (CH3), 91.7,
112.1, 117.5, 126.7, 129.6, 151.4, 162.4 (C=O), 171.3 (C=S) ppm; MS: m/z (%) = M+ , 447 (3), 377
(26), 286 (16), 198 (14), 149 (57), 125 (100); Anal. calcd. for C17H17N7O4S2 (447.49): C, 45.63; H,
3.83; N, 21.91. Found: C, 45.91; H, 3.81; N, 22.12.
5,5'-[(4-Bromophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8d).
Yield: 93%; m.p. = 224–226 °C; IR (KBr) νmax (cm−1): 3442, 3308 (NH2 and NH), 3060 (CH arom.),
1
2946 (CH aliph.), 1727 (C=O), 1569 (C=N), 1142, 1077 (C=S); H-NMR (DMSO-d6): 12.28 (s, 2H,
2NH), 7.58 (bs, 4H, 2NH2), 7.39–7.37 (d, J = 5.8, 2H, arom.), 7.09–7.07 (d, J = 9.1, 2H, arom.), 5.46
13
(s, 1H, CH-5), 3.77 (s, 6H, 2 CH3); C-NMR (DMSO-d6): δ = 28.3 (CH), 38.7 (CH3), 91.4, 111.8,
117.3, 126.0, 129.2, 151.2, 162.4 (C=O), 171.3 (C=S) ppm; MS: m/z (%) = M+ + 2, 483 (5), M+, 481
(14), 449 (84), 249 (60), 208 (100), 193 (97), 167 (60); Anal. calcd. for C17H17BrN6O2S2 (481.38): C,
42.42; H, 3.56; N, 17.46 Found: C, 42.53; H, 3.58; N, 17.63.
5,5'-[(2-Hydroxyphenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydro-pyrimidin-4(1H)-one)
(8e). Yield: 89%; m.p. = 248–250 °C; IR (KBr) νmax (cm−1): 3628 (OH), 3443, 3315 (NH2 and NH),
3028 (CH arom.), 2946 (CH aliph.), 1632 and 1602 (C=O), 1482 (C=N), 1145, 1087 (C=S); 1H-NMR
(DMSO-d6): 13.82 (s, 1H, OH), 12.54 (s, 2H, 2NH), 7.29 (bs, 4H, 2NH2), 7.24–7.21 (d, J = 6.0, 1H,
arom.), 7.18–7.16 (d, J = 6.0, 1H, arom.), 7.13–7.11 (m, 2H, arom.), 5.62 (s, 1H, CH-5), 3.80 (s, 6H,
13
2 CH3); C-NMR (DMSO-d6): δ = 28.3 (CH), 39.1 (CH3), 91.2, 112.3, 117.6, 126.3, 128.3, 129.7,
131.3, 152.0, 162.2 (C=O), 171.1 (C=S) ppm; MS: m/z (%) = M+, 418 (1), 377 (5), 97 (12), 91 (100);
Anal. calcd. for C17H18N6O3S2 (418.49): C, 48.79; H, 4.34; N, 20.08. Found: C, 48.88; H, 4.42; N, 20.32.
3.5. Synthesis of 5-Aryl-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido[5',4':5,6]pyrido
[2,3-d]pyrimidine-4,6(1H,7H)-diones (9a–e)
Two methods were used to synthesize the target Compounds 9a–e:
A. A mixture of acetic acid/HCl (1:1, 2mL) was added to 6-amino-1-methyl-2-thiouracil (1) (0.26 g,
1.2 mmol) and appropriate aromatic aldehydes (1.2 mmol). The mixture was heated under reflux
for 4–6 h. After cooling, the formed precipitate was filtered, washed with ethanol and crystallized
from DMF, affording 9a–e.
B. A mixture of 5,5′-arylmethylene bis(6-amino-1-methyl-2-thiouracil) (8a) (0.1 g, 0.22 mmol) and
acetic acid/HCl (1:1, 2 mL) was heated under reflux for 1 h. After cooling, the formed precipitate
was filtered, washed with ethanol and crystallized from DMF to afford 9a.

Molecules 2015, 20
19272
5-(4-Chlorophenyl)-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]
pyrimidine-4,6(1H,7H)-dione (9a). Yield (method A): 84%, (method B): 67%; m.p. = 298–300 °C;
reflux 4 h; IR (KBr) νmax (cm−1): 3219 (NH), 3046 (CH arom.), 2818 (CH aliph.), 1704 (C=O), 1561
(C=N), 1103, 1052 (C=S); 1H-NMR (DMSO-d6): 12.58 (s, 1H, NH), 12.50 (s, 1H, NH), 8.32 (s, 1H, NH
(10)), 8.15–8.13 (d, J = 5.9, 1H, arom.), 7.94–7.92 (d, J = 8.9, 1H, arom.), 7.69–7.67 (d, J = 6.0, 1H,
arom.), 7.57–7.55 (d, J = 8.8, 1H, arom.), 6.08 (s, 1H, CH-5), 3.57 (s, 3H, NCH3), 3.52 (s, 3H, NCH3);
13C-NMR (DMSO-d6): δ = 33.46 (CH), 45.9 (CH3), 95.08, 127.9, 128.2, 128.9, 129.52, 131.20, 161.9
(C=O), 169.8 (C=S) ppm; MS: m/z (%) = M+ + 2, 422 (0.3), M+, 420 (1), 129 (19), 74 (39), 69 (100);
Anal. calcd. for C17H14ClN5O2S2 (419.90): C, 48.63; H, 3.36; N, 16.68. Found: C, 49.02; H, 2.86;
N, 17.01.
1,9-Dimethyl-5-(3-nitrophenyl)-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]
pyrimidine-4,6(1H,7H)-dione (9b). Yield (method A): 86%; m.p. >300 °C; reflux 5 h; IR (KBr) νmax
(cm−1): 3461 (NH), 3060 (CH arom.), 2856 (CH aliph.), 1729 (C=O), 1582 (C=N), 1166, 1092 (C=S);
1H-NMR (DMSO-d6): 12.56 (s, 1H, NH), 12.05 (s, 1H, NH), 8.15 (s, 1H, NH(10)), 8.06 (s, 1H, arom.),
7.96–7.48 (m, 3H, arom.), 6.22 (s, 1H, CH-5), 3.58 (s, 3H, NCH3), 3.52 (s, 3H, NCH3); 13C-NMR
(DMSO-d6): δ = 33.56 (CH), 46.33 (CH3), 95.24, 126.72, 127.45, 128.12, 128.43, 129.21, 129.91,
151.82, 162.40 (C=O), 171.3 (C=S) ppm; MS: m/z (%) = M+, 430 (5), 428 (16), 299 (18), 106 (100);
Anal. calcd. for C17H14N6O4S2 (430.46): C, 47.43; H, 3.28; N, 19.52. Found: C, 47.94; H, 2.85; N, 19.97.
1,9-Dimethyl-5-(4-nitrophenyl)-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]
pyrimidine-4,6(1H,7H)-dione (9c). Yield (method A): 83%; m.p. >300 °C; reflux 4 h, IR (KBr) νmax
(cm−1): 3384 (NH), 3034 (CH arom.), 2918 (CH aliph.), 1705 (C=O), 1520 (C=N), 1134, 1086 (C=S);
1H-NMR (DMSO-d6): 11.93 (s, 2H, 2NH), 8.46 (s, 1H, NH(10)), 8.06–8.04 (s, J = 7.5, 2H, arom.),
13
7.29–7.27 (s, J = 7.5, 2H, arom.), 6.20 (s, 1H, CH-5), 3.51 (s, 6H, 2 NCH3); C-NMR (DMSO-d6):
δ = 33.55 (CH), 46.41 (CH3), 95.27, 128.11, 128.43, 128.93, 129.86, 151.34, 161.93 (C=O), 169.78
(C=S) ppm; MS: m/z (%) = M+, 430 (1), 332 (24), 106 (68), 91 (14), 78 (100); Anal. calcd. for
C17H14N6O4S2 (430.46): C, 47.43; H, 3.28; N, 19.52. Found: C, 48.01; H, 2.86; N, 19.93.
5-(4-Bromophenyl)-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]
pyrimidine-4,6(1H,7H)-dione (9d). Yield (method A): 90%; m.p. >300 °C; reflux 4 h; IR (KBr) νmax
(cm−1): 3220 (NH), 3046 (CH arom.), 2818 (CH aliph.), 1721 (C=O), 1567 (C=N), 1107, 1068 (C=S);
1H-NMR (DMSO-d6): 12.61 (s, 1H, NH), 12.52 (s, 1H, NH), 8.28–8.26 (d, 1H, arom.), 8.05–8.03 (d,
J = 8.6, 1H, arom.), 7.99–7.97 (d, J = 8.8, 2H, arom.), 7.84 (s, 1H, NH(10)), 6.06 (s, 1H, CH-5), 3.56 (s,
13
3H, NCH3), 3.51 (s, 3H, NCH3); C-NMR (DMSO-d6): δ = 33.48 (CH), 45.88 (CH3), 95.16, 127.89,
128.16, 128.91, 129.47, 151.16, 161.89 (C=O), 169.77 (C=S) ppm; MS: m/z (%) = M+ + 2, 466 (2),
M+, 464 (6), 200 (58), 95 (100); Anal. calcd. for C17H14BrN5O2S2 (464.35): C, 43.97; H, 3.04; N, 15.08
Found: C, 44.34; H, 2.60; N, 15.31.
5-(2-Hydroxyphenyl)-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]
pyrimidine-4,6(1H,7H)-dione (9e). Yield (method A): 81%; m.p. >300 °C; reflux 6 h; IR (KBr) νmax
(cm−1): 3654 (OH), 3321 (NH), 3096 (CH arom.), 2901 (CH aliph.), 1684 (C=O), 1580 (C=N), 1141,
1081 (C=S); 1H-NMR (DMSO-d6): 12.44 (s, 1H, OH), 12.36 (s, 1H, NH), 10.96 (s, 1H, NH), 8.40–8.38

Molecules 2015, 20
19273
(d, 1H, arom.), 8.36–8.34 (d, 1H, arom.), 8.28–8.26 (d, 1H, arom.), 7.88 (s, 1H, NH(10)), 6.91–6.89 (d,
13
1H, arom.), 6.17 (s, 1H, CH-5), 3.56 (s, 6H, 2 NCH3); C-NMR (DMSO-d6): δ = 33.46 (CH), 45.64
(CH3), 95.05, 115.02, 127.84, 128.12, 128.76, 129.32, 131.14, 151.24, 161.85 (C=O), 169.73 (C=S)
ppm; MS: m/z (%) = M+, 401 (0.4), 109 (36), 106 (100), 78 (51), 43 (52); Anal. calcd. for
C17H15N5O3S2 (401.46): C, 50.86; H, 3.77; N, 17.44. Found: C, 51.27; H, 3.31; N, 17.70.
4. Antimicrobial Activity
4.1. Microorganisms and Culture Media
Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative) and Candida albicans
(yeast) were obtained from the microbiology lab of the Faculty of Medicine, Jazan University Culture
Collection. All bacteria strains were maintained and kept at −80 °C until used. Müller–Hinton agar
(MHA) and Sabouraud dextrose agar (SDA) were obtained from the microbiology lab of the Faculty of
Medicine, Jazan University.
4.2. Disc Diffusion Method
The disc diffusion method for antimicrobial susceptibility testing was carried out according to the
standard method [26] to assess the presence of antibacterial activities of the tested chemical substances.
A microbial culture (which has been adjusted to 0.5 McFarland standards) was used to inoculate
Müller–Hinton agar and Sabouraud dextrose agar plates evenly using a sterile swab. The plates were dried
for 15 min and then used for the sensitivity test. The discs that had been impregnated with 1 mg/mL of
the chemical samples were placed on the Müller–Hinton agar and Sabouraud dextrose agar surface.
Each test plate comprises six discs: one negative control (disc with the used solvent) and five treated
discs. The negative control was DMSO (100%). Besides the controls, each plate had five treated discs
were placed about equidistant from each other. The plate was then incubated at 37 °C for 18–24 h
depending on the species of bacteria or yeast used in the test. After the incubation, the plates were
examined for the inhibition zone. The inhibition zone was then measured using calipers and recorded.
The test was performed in triplicates to ensure reliability.
4.3. Minimum Inhibition Concentration Determination
Minimum inhibition concentration determination was performed according to the method described
in [27–29]. Serial dilutions of the chemical substances that showed antimicrobial activity with the disc
diffusion method (a reasonable inhibition zone) (a range of 10 dilutions from 0.1 µg/mL up to 1 µg/mL)
are added to a Müller–Hinton or and Sabouraud dextrose broth medium in separate test tubes. These
tubes are then inoculated with the microorganism that one wishes to test (Staphylococcus aureus,
Escherichia coli or Candida albicans). The tubes are allowed to incubate overnight. Broth tubes that
appear turbid are indicative of bacterial growth, while tubes that remain clear indicate no growth. The
MIC of the antibiotic is the lowest concentration that does not show growth.

Molecules 2015, 20
19274
5. Conclusions
Simple methylation methods were used for the methylation of S-H and N-H in the 2-thioxanthines.
Also, the formation of tricyclic dipyrimidopyridines was developed. Compounds 7d and 9a showed a
significant effect against Staphylococcus aureus and Candida albicans.
Acknowledgments
We wish to thank Asmaa Amar for carrying out the antimicrobial activity for the newly-synthesized
compounds in the microbiology laboratory, Faculty of Medicine, Jazan University.
Author Contributions
Samar El-kalyoubi and Fatmah Agili formulated the research idea, conceived and prepared the
manuscript; Samar El-kalyoubi and Fatmah Agili performed the experiments; Samar El-kalyoubi and
Fatmah Agili analyzed the data; Samar El-Kalyoubi and Shaker Youssif wrote the paper. All authors
have read and approved the final manuscript.
Conflicts of Interest
The authors declare no conflict of interest.
References
1. Wamhoff, H.; Dzenis, J.; Hirota, K. Uracils: Versatile Starting Materials in Heterocyclic Synthesis.
Adv. Heterocycl. Chem. 1992, 55, 129–259.
2. González-Vallinas, M.; Molina, S.; Vicente, G.; Cueva, A.; Vargas, T.; Santoyo, S.; García-Risco, M.R.;
Fornari, T.; Reglero, G.; Molina, A.R. Antitumor effect of 5-fluorouracil is enhanced by rosemary
extract in both drug sensitive and resistant colon cancer cells. Pharmacol. Res. 2013, 72, 61–68.
3. Kumar, A.; Sinha, S.; Chauhan, P.M. Syntheses of novel antimycobacterial combinatorial libraries
of structurally diverse substituted pyrimidines by three-component solid-phase reactions. Bioorg. Med.
Chem. Lett. 2002, 12, 667–669.
4. Baraldi, P.G.; Pavani, M.G.; Nunez, M.; Nuñez, M.C.; Brigidi, P.; Vitali, B.; Gambari, R.;
Romagnoli, R. Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and
their transformation in triazolo-, imidazo-, and pyrazolopirimidines. Bioorg. Med. Chem. 2002,
10, 449–456.
5. Nasr, M.N.; Gineinah, M.M. Pyrido[2,3-d]pyrimidines and pyrimido[5′,4′:5,6]pyrido[2,3-d]pyrimidines
as new antiviral agents: Synthesis and biological activity. Arch. Pharm. 2002, 335, 289–295.
6. Nagarapu, L.; Vanaparthi, S.; Bantu, V.; Kumar, C.G. Synthesis of Novel Benzo[4,5]thiazolo[1,2-a]
pyrimi-dine-3-carboxylate Derivatives and Biological Evaluation as Potential Anticancer Agents.
Eur. J. Med. Chem. 2013, 69, 817–822.

Molecules 2015, 20
19275
7. Sondhi, S.M.; Johar, M.; Rajvanshi, S.; Dastidar, S.G.; Shukla, R.; Raghubir, R.; Lown; J.W.
Anticancer, anti-inflammatory and analgesic activity evaluation of heterocyclic compounds synthesized
by the reaction of 4-isothiothiocyanato-4-methylpentan-2-one with substituted o-phenylenediamines,
o-diaminopyridine and (un)substituted o-diaminopyrimidines. Aust. J. Chem. 2001, 54, 69–74.
8. Saenger, W. Principles of Nucleic Acid Structure; Springer: New York, NY, USA, 1984; p. 556.
9. Ono, M; Kawakami, M. Separation of newly-synthesized RNA by organomercurial agarose affinity
chromatography. J. Biochem. 1977, 81, 1247–1252.
10. Leszczynski, J. Tautomers of 6-thioguanine: Structures and properties. J. Phys. Chem. 1993, 97,
3520–3524.
11. Nagdi, L.; Galy, J.P.; Barbe, J.; Cremieux, A.; Chevalier, J.; Sharples, D. Some new 1-nitro acridine
derivatives as antimicrobial agents. Eur. J. Med. Chem. 1990, 25, 67–70.
12. Pawlak, K.; Pawlak, J.W.; Konopa, J. Cytotoxic and antitumor activity of 1-nitroacridines as an
aftereffect of their interstrand DNA cross-linking. Cancer Res. 1984, 44, 4289–4296.
13. Gunaratnam, M.; Green, C.; Moreira, J.B.; Moorhouse, A.D.; Kelland, L.R.; Moses, J.E.; Neidle,
S. G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro
and in vivo. Biochem. Pharmacol. 2009, 78, 115–122.
14. Nesměrák, K.; Pospíšek, M.; Zikánová, B.; Němec, I.; Barbe, J.; Gabriel, J. Effect of structure on
antibiotic action of new 9-(ethylthio)acridines. Folia Microbiol. 2002, 47, 118–120.
15. Besly, D.M.; Goldberg, A.A. Potential antimalarial derivatives of triaza-anthracene J. Chem. Soc.
1957, 4997–5001.
16. Bruce-Chwatt, L.J.; Archibald, H.M. Field trials of new antimalarials in West Africa. Br. Med. J.
1953, 1, 539–541.
17. Greenwood, D. Conflicts of interest: The genesis of synthetic antimalarial agents in peace and
war. J. Antimicrob. Chemother. 1995, 36, 857–872.
18. Wainwright, M.; Phoenix, D.A.; Marland, J.; Wareing, D.R.; Bolton, F.J. In-vitro photobactericidal
activity of aminoacridines. J. Antimicrob. Chemother 1997, 40, 587–589.
19. Robins, R.K.; Dille, K.J; Willits, C.H.; Christensen, B.E. Purines. II. The Synthesis of Certain
Purines and the Cyclization of Several Substituted 4,5-Diaminopyrimidines. J. Am. Chem. Soc.
1953, 75, 263–266.
20. Bergmann, F.; Levin, G.; Kalmus, A.; Kwietny-Govrin, H. Synthesis and Properties of
3-Methylpurines. J. Org. Chem. 1961, 26, 1504–1508.
21. Youssif, S.; Agili, F.; Mohamed, S.F. Syntheis, Antiviral and Antimicrobial activities of New
Substituted Thioxanthines and Thiolumazines. J. Appl. Sci. Res. 2009, 5, 1844–1852.
22. Stanovnik, B; Tisler, M.; Hribar, A.; Barlin, G.B.; Brown, D.J. Methylation of heterocyclic
compounds containing NH, SH and/or OH groups by means of N,N-dimethylformamide dimethyl
acetal. Aust. J. Chem. 1981, 34, 1729–1738.
23. Lamoureux, G.; Agüero, C. A comparison of several modern alkylating agents. Arkivoc 2009, 1,
251–264.
24. Youssif, S.; El-Bahaie S.; Nabih, E. A Facile One-pot Synthesis of Fused 2-Thiouracils:
Dipyrimidinopyridine, Pyrazolopyrimidine and Pyridazinopyrimidines. Bull. Korean Chem. Soc.
2003, 24, 1429–1432.

Molecules 2015, 20
19276
25. Youssif, S.; Mohamed, S.F. 6-Amino-2-thio- and 6-Aminouracils as Precursors for the Synthesis
of Antiviral and Antimicrobial Methylenebis(2-thiouracils), Tricyclic Pyrimidines, and
6-Alkylthiopurine-2-ones. Chem. Mon. 2008, 139, 161–168.
26. Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic susceptibility testing by a
standardized single disk method. Am. J. Clin. Pathol. 1966, 45, 493–496.
27. Wiegand, I.; Hilpert, K.; Hancok, R.E. Agar and broth dilution methods to determine the minimal
inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 2008, 3, 163–175.
28. Hammer, K.A.; Carson, C.F.; Riley, T.V. Susceptibility of transient and commensal skin flora to
the essential oil of Melaleuca alternifolia (tea tree oil). Am. J. Infect. Control 1996, 24, 186–189.
29. Turnidge, J.D.; Ferraro, M.J.; Jorgensen, J.H. Susceptibility Test Methods. General Considerations.
In Manual of Clinical Microbiology, 8th ed.; Murray, P.R., Baron, E.J., Jorgensen, J.H., Pfaller, M.A.,
Yolken, R.H., Eds.; ASM Press: Washington, DC, USA, 2003.
Sample Availability: Not available
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/4.0/).